A delayed clinical trial actually boosted Bristol Myers Squibb’s stock.
Here’s why.
-
Bristol Myers’ stock rallied Wednesday as investors maintained high hopes
for Cobenfy as an Alzheimer’s treatment, even though the outcome of a
late-stage ...
38 minutes ago







Catholic bishops in various parts of the country stepped up their campaign against the Reproductive Health (RH) bill.
ReplyDelete